MIRA INFORM REPORT

 

 

Report Date :

28.02.2013

 

IDENTIFICATION DETAILS

 

Name :

HAW PAR (INDIA) PRIVATE LIMITED (w.e.f. 22.06.2009)

 

 

Formerly Known As :

HAW PAR ELDER (INDIA) PRIVATE LIMITED (w.e.f. 09.08.1995)

 

HAW PAR MEDICALS (INDIA) PRIVATE LIMITED

 

 

Registered Office :

811 / 8th Floor, FILIX, Opposite Asain Paints Gate, L.B.S. Marg, Bhandup (West), Mumbai – 400 078, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

09.08.1995

 

 

Com. Reg. No.:

11-091579

 

 

Capital Investment / Paid-up Capital :

Rs. 80.000 millions

 

 

CIN No.:

[Company Identification No.]

U24230MH1995PTC091579

 

 

PAN No.:

[Permanent Account No.]

AAACH8946H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Ayurvedic products.

 

 

No. of Employees :

Not divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 87900

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “HAW PAR HEALTHCARE; Singapore”

 

It is an established company having a moderate track record. There appears some accumulated losses recorded by the company.

 

There appears drastic fall in the sales turnover during the current year.

 

However, trade relations are reported to be fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with great caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Uday Randive

Designation :

Country Manager

Contact No.:

91-22-67417060

Date :

25.02.2013

 

 

LOCATIONS

 

Registered Office :

811 / 8th Floor, FILIX, Opposite Asain Paints Gate, L.B.S. Marg, Bhandup (West), Mumbai – 400 078, Maharashtra, India

Tel. No.:

91-22-67417060

Fax No.:

Not Available

E-Mail :

udayrandive@hph.hawpar.com

 

 

DIRECTORS

 

As on 28.09.2012

 

Name :

Mr. Ah Kuan Han

Designation :

Director

Address :

101, Jalan Binchang, Singapore 578570

Date of Birth/Age :

04.06.1948

Date of Appointment :

22.07.1998

DIN No.:

01403006

 

 

Name :

Mr. Bee Leong Goh

Designation :

Director

Address :

23, Jalan Asuhan, Singapore 299346

Date of Birth/Age :

06.03.1954

Date of Appointment :

07.04.2003

DIN No.:

01421430

 

 

Name :

Mr. Ee Lim Wee

Designation :

Director

Address :

6, Camden Park, Singapore 299796

Date of Birth/Age :

27.08.1961

Date of Appointment :

01.04.2003

DIN No.:

01403026

 

 

Name :

Mr. Sein Hao Tarn

Designation :

Director

Address :

9, Jalan Angklong, Singapore 578712

Date of Birth/Age :

17.03.1967

Date of Appointment :

01.04.2003

DIN No.:

01403052

 

 

KEY EXECUTIVES

 

Name :

Mr. Uday Randive

Designation :

Country Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 28.09.2012

 

Names of Shareholders

 

No. of Shares

 

 

 

Haw Par Healthcare Limited, Singapore

 

7999999

Ah Kuan Han

 

1

 

 

 

TOTAL

 

8000000

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

 

Line of Business :

Trader of Ayurvedic products.

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

Not Divulged

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Price Waterhouse

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai – 400 028, Maharashtra, India

PAN No.:

AAEFP5579P

 

 

Holding Company :

Haw Par Healthcare Limited, Singapore

 

 

CAPITAL STRUCTURE

 

As on 28.09.2012

 

Authorized Capital:

 

No. of Shares

Type

Value

Amount

 

 

 

 

8000000

Equity Shares

Rs. 10/- each

Rs. 80.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital:

 

No. of Shares

Type

Value

Amount

 

 

 

 

8000000

Equity Shares

Rs. 10/- each

Rs. 80.000 millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

80.000

50.000

50.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

(58.014)

(58.919)

0.000

4] (Accumulated Losses)

0.000

0.000

(53.079)

NETWORTH

21.986

(8.919)

(3.079)

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.316

0.316

0.316

TOTAL BORROWING

0.316

0.316

0.316

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

22.302

(8.603)

(2.763)

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.515

0.047

0.063

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERRED TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

0.000

0.000

 

Sundry Debtors

52.079

38.441

11.444

 

Cash & Bank Balances

11.911

9.656

10.411

 

Other Current Assets

0.000

0.027

0.011

 

Loans & Advances

8.220

2.340

1.964

Total Current Assets

72.210

50.464

23.830

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

26.814

36.491

12.167

 

Other Current Liabilities

23.609

22.623

14.489

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

50.423

59.114

26.656

Net Current Assets

21.787

(8.650)

(2.826)

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

22.302

(8.603)

(2.763)

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income (Gross Sales)

 

112.762

212.888

 

 

Other Income

 

NA

NA

 

 

TOTAL                                    

 

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

 

NA

NA

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX

 

2.223

(5.839)

 

 

 

 

 

Less

TAX                                                                 

 

0.450

0.000

 

 

 

 

 

 

PROFIT/(LOSS)  AFTER TAX

 

1.773

(5.839)

 

 

 

 

 

 

Earnings/(Loss)  Per Share (Rs.)

 

22.16

--

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

Net Profit Margin

(PBT/Sales)

(%)

1.97

(2.74)

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.05

(11.56)

NA

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.10

(0.65)

NA

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.01

(0.03)

(0.10)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.43

0.85

0.89

 

 

LOCAL AGENCY FURTHER INFORMATION

 

SUNDRY CREDITORS DETAILS:

 

Particulars

31.03.2012

 

31.03.2011

31.03.2010

 

(Rs. In Millions)

 

 

 

 

Trade Payables

26.814

36.491

12.167

 

 

 

 

TOTAL

26.814

36.491

12.167

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

----

14]

Estimation for coming financial year

 

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----

22]

Litigations that the firm / promoter involved in

----

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

----

26]

Buyer visit details

----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE:

 

The registered office of the company has been shifted from Unit No. 240 – B, Crystal Plaza, New Link Road, Andheri (West), Mumbai – 400 053, Maharashtra, India to the present address w.e.f. 31.10.2011

 

 

GENERAL INFORMATION

 

Subject is engaged in business of trading in Ayurvedic products. The Company was incorporated in 1995 and is based in Mumbai, India. Subject operates as a subsidiary of Haw Par Healthcare Limited, a multinational company headquartered in Singapore. Haw Par Healthcare Limited is the master licensee of world renowned Tiger Balm Brand with presence in over 100 countries.

 

 

UNSECURED LOAN:

                                                                                                                                           (Rs. in Millions)

Particulars

As on 31.03.2012

 

As on 31.03.2011

 

 

 

 

Loans and Advances from related parties

0.316

0.316

 

 

 

TOTAL

0.316

0.316

 

 

CONTINGENT LIABILITY

 

Demand raised by Income tax Authorities against which the Company has filed an appeal - Rs. 0.875 millions (Previous Year: Rs. 0.875 millions). Future outflow in respect of above is determinable only on receipt of judgement / decision pending with Income Tax authorities.

 

 

PRESS RELEASE

 

STRIDES SIGNS AGREEMENT WITH HAW PAR HEALTHCARE

 

Sep 02, 2006

 

Strides Arcolab and Haw Par Healthcare, Singapore have today entered into a share purchase agreement, which provides for Strides Singapore Pte Limited (an indirect wholly owned subsidiary of Strides Arcolab Limited) to acquire 100% of DHA for a consideration of approximately S$19.7m, which was arrived at on a willing-buyer and willing-seller basis. Transaction is subject to customary closing conditions and is expected to complete within September 2006.

 

Commenting on the acquisition Arun Kumar, Vice Chairman and Managing Director Strides Arcolab said:

 

The signing of the share purchase agreement with Haw Par Healthcare is the key strategic initiative for Strides to continue to grow through regional strategies alongside global partnerships.

 

Established in 1969, DHA is one of the largest generics pharmaceutical manufacturers in Singapore. It is also an important pharma player in Malaysia and Hong Kong amongst other markets. For the financial year ended December 2005, DHA posted sales revenue of S$16.36 million and PAT of S$2.72 million.

 

DHA has a GMP certified manufacturing facility in Jurong, the industrial heartland of Singapore which manufactures a range of pharmaceutical products.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.84

UK Pound

1

Rs.81.24

Euro

1

Rs.70.39

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

NID

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

NB

New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.